Pre-emptive strategies to mitigate these toxicities, such as the use of IL-6 inhibitors for managing CRS or corticosteroids for neurotoxicity, can also play a crucial role in managing side effects [118, 119]. This evidence concerns the gene IL6 and congenital rubella syndrome.